ArticleGenes2023

Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia.

Holm Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.